Eiko Lifesciences Ltd (EIKO) Fair Value & Analysis
Basic Materials · IN · Market cap ₹719M
Fair value as of: Aug 13, 2026
From 23 valuation models · updated 6 days ago
Below-average quality, screening 12% undervalued on our models.
What matters now
- A fairly wide model range (₹34.98 to ₹66.60) leaves room in how you read the outcome.
- Our model range runs from ₹34.98 (bear) to ₹66.60 (bull), base ₹53.28. The closer the price sits to the lower half, the larger the margin of safety.
- Quality 49/100 (below-average quality) with high evidence: the data supports the verdict.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 13, 2026.
How to read this chart
60‑month range ₹19.63 – ₹86.66 · fair‑value band ₹34.98 – ₹66.60 · the ₹47.55 price screens below the ₹53.28 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Aug 13, 2026.
Analysis
Eiko Lifesciences Ltd (EIKO) currently trades at ₹47.55, while our model-based Fair Value estimate is ₹53.28, implying the stock looks roughly 12.1% undervalued today. The Quality Score stands at 49/100 (below-average quality), in the Basic Materials sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high), always confirm before acting.
Over the trailing twelve months, Eiko Lifesciences Ltd generated revenue of ₹527M at a net margin of 8.5%. Revenue grew 62.7% year over year. It earns a return on equity of 8.4%. Net debt stands at ₹44.1M. Fundamentals as of Aug 13, 2026
Our scenario range runs from ₹34.98 (bear case) to ₹66.60 (bull case); at ₹47.55, the current price sits within that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 26% below its 52-week high and 4% above its 52-week low, currently below its 200-day average. For context, the median of 10 Basic Materials peers we cover trades at -68% fair-value upside, at 12%, EIKO screens cheaper than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 23 models by family
Widest divergence: Growth Earnings (₹134.96) versus Asset-Based (₹32.12). Highest evidence: Growth DCF (80).
Notify me when EIKO reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Aug 13, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 51 · Market factors (momentum, volatility) 37
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
Eiko LifeSciences Limited manufactures and sells specialty and fine chemicals in India. The company operates through Specialty Chemicals; Pharma Intermidiates; Food Additives; Oleo Chemicals; and Cosmetic Ingredients segments. The company offers organic and inorganic specialty chemicals.
Full company description
Eiko LifeSciences Limited manufactures and sells specialty and fine chemicals in India. The company operates through Specialty Chemicals; Pharma Intermidiates; Food Additives; Oleo Chemicals; and Cosmetic Ingredients segments. The company offers organic and inorganic specialty chemicals. Its products are used in pharmaceuticals, agrochemicals, aroma chemicals, electronic chemicals, etc. In addition, the company is involved in processing, formulating, producing, buying, selling, and exporting of specialty and fine chemicals. The company was formerly known as Narendra Investments (Delhi) Limited and changed its name to Eiko LifeSciences Limited in June 2021. Eiko LifeSciences Limited was incorporated in 1977 and is based in Thane, India.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2022 – FY2026 · reported fiscal years
Eiko Lifesciences Ltd reported revenue of ₹527M in FY2026 versus ₹254M in FY2022, a compound +20.0%/yr. Reported net income was ₹45.0M in FY2026, compounding +58.9%/yr from FY2022.
Watch EIKO: get an alert when its fair value changes →
Peer Group
Specialty Chemicals · 675 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Specialty Chemicals median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Specialty Chemicals stocks, each showing price versus our Fair Value estimate (as of Aug 13, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Linde plc LIN | $479.43 | $222.03 | -54% |
| Wanhua Chemical Group 600309 | ¥75.06 | ¥68.03 | -9% |
| Asian Paints Limited ASIANPAINT | ₹2,630 | ₹696.23 | -74% |
| Solar Industries India Limited SOLARINDS | ₹18,730 | ₹2,793 | -85% |
| Pidilite Industries Limited PIDILITIND | ₹1,702 | ₹351.84 | -79% |
| PT Chandra Asri Pacific Tbk TPIA | 2,160 IDR | 2,322 IDR | +8% |
| Berger Paints India Limited BERGEPAINT | ₹541.00 | ₹156.35 | -71% |
| Gujarat Fluorochemicals Limited FLUOROCHEM | ₹4,680 | ₹724.88 | -85% |
| Himadri Speciality Chemical Limited HSCL | ₹778.15 | ₹248.63 | -68% |
| Enaex S.A ENAEX | 25,050 CLP | 23,574 CLP | -6% |
Compare Eiko Lifesciences Ltd with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Basic Materials stocks →
Frequently asked questions
Is Eiko Lifesciences Ltd (EIKO) overvalued or undervalued?
What is the fair value of EIKO?
What is the quality score of EIKO?
What is the revenue of Eiko Lifesciences Ltd (EIKO)?
What is the net profit margin of EIKO?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track Eiko Lifesciences Ltd and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.